[72] compared the efficacy of first-line use of infliximab versus conventional exclusive enteral nutrition or prednisolone in therapy-naïve, new-onset pediatric patients with CD. They reconfirmed the superiority of infliximab therapy over conventional therapy in terms of clinical remission rate. ...